Suppr超能文献

在人类中,组胺和毒蕈碱能机制是对合成人胃泌素(1-17)作出反应时胃酸分泌的重要介质。

In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17).

作者信息

Zimmerhackl B, Wünsch E, Classen M, Schusdziarra V, Schepp W

机构信息

Department of Medicine II, Technical University, Munich, Germany.

出版信息

Regul Pept. 1993 Jul 23;46(3):583-92. doi: 10.1016/0167-0115(93)90260-f.

Abstract

It is still controversial whether gastrin stimulates acid secretion by interacting with specific gastrin receptors on parietal cells or via endogenous mediators, e.g., histamine. Therefore, it was our aim to determine in healthy human volunteers (n = 14; 3 females, 11 males; age 23-28 years) the degree by which the specific histamine H2-receptor antagonist famotidine or the muscarinergic antagonist atropine block acid secretion in response to synthetic human gastrin (hG) (1-17). Famotidine was deliberately administered at a supramaximal dose (40 mg i.v. bolus) to reliably block any and all effects of endogenous histamine on the parietal cells. After an overnight fast famotidine or saline were injected i.v., and gastric secretions were collected via a nasogastric tube for the ensuing 60 min to assess basal secretion. Thereafter, hG (1-17) was infused for 60 min in randomized order at two different rates: 0.75 ng/kg/min resulting in postprandial plasma gastrin levels (55-66 pg/ml), and 1.5 ng/kg/min yielding supraphysiologic levels (110-136 pg/ml). Both rates increased basal acid secretion (meq/10 min) from 0.5 +/- 0.2 to 3.8 +/- 0.6 and 4.7 +/- 0.5, respectively. Famotidine abolished basal acid secretion and completely blocked acid and volume secretion in response to both hG (1-17) doses. After injection of famotidine both hG (1-17) doses resulted in plasma levels exceeding those in controls by 18-27 pg/ml. A similar increase (14-16 pg/ml) was observed after famotidine injection without simultaneous hG (1-17) infusion indicating that this increase was due to the release of endogenous gastrin when the acid feedback inhibition was blocked by famotidine. To study a potential additional role of cholinergic mechanisms the effect of atropine (7 micrograms/kg i.m.) on hG (1-17)-induced acid secretion was examined. Atropine reduced basal acid secretion from 0.8 +/- 0.1 to 0.1 +/- 0.08 meq/15 min. Similarly, the response to 0.75 ng/kg/min hG (1-17) was reduced by 72.9%. Basal gastrin release was not altered by atropine which, however, tended to increase serum gastrin levels during infusion of hG (1-17) by 16-24 pg/ml. We conclude that in man histamine and muscarinic mechanisms are essential mediators of gastrin-stimulated acid secretion. The present data argue against a significant direct effect of gastrin alone on human parietal cells but rather support potentiating interaction with histamine and cholinergic mechanisms.

摘要

胃泌素是通过与壁细胞上的特定胃泌素受体相互作用还是通过内源性介质(如组胺)来刺激胃酸分泌,目前仍存在争议。因此,我们的目的是在健康人类志愿者(n = 14;3名女性,11名男性;年龄23 - 28岁)中确定特异性组胺H2受体拮抗剂法莫替丁或毒蕈碱能拮抗剂阿托品阻断合成人胃泌素(hG)(1 - 17)刺激胃酸分泌的程度。法莫替丁特意以超最大剂量(静脉推注40 mg)给药,以可靠地阻断内源性组胺对壁细胞的任何和所有作用。禁食过夜后,静脉注射法莫替丁或生理盐水,并通过鼻胃管收集随后60分钟的胃分泌物以评估基础分泌。此后,以两种不同速率随机顺序输注hG(1 - 17)60分钟:0.75 ng/kg/min导致餐后血浆胃泌素水平(55 - 66 pg/ml),1.5 ng/kg/min产生超生理水平(110 - 136 pg/ml)。两种速率分别使基础胃酸分泌(meq/10分钟)从0.5±0.2增加到3.8±0.6和4.7±0.5。法莫替丁消除了基础胃酸分泌,并完全阻断了对两种hG(1 - 17)剂量的胃酸和胃液分泌反应。注射法莫替丁后,两种hG(1 - 17)剂量导致的血浆水平比对照组高18 - 27 pg/ml。在未同时输注hG(1 - 17)的情况下注射法莫替丁后观察到类似的升高(14 - 16 pg/ml),这表明这种升高是由于法莫替丁阻断酸反馈抑制时内源性胃泌素的释放。为了研究胆碱能机制的潜在额外作用,研究了阿托品(7微克/千克肌肉注射)对hG(1 - 17)诱导的胃酸分泌的影响。阿托品使基础胃酸分泌从0.8±0.1降低到0.1±0.08 meq/15分钟。同样,对0.75 ng/kg/min hG(1 - 17)的反应降低了72.9%。阿托品未改变基础胃泌素释放,但在输注hG(1 - 17)期间倾向于使血清胃泌素水平升高16 - 24 pg/ml。我们得出结论,在人类中,组胺和毒蕈碱能机制是胃泌素刺激胃酸分泌的重要介质。目前的数据反对胃泌素单独对人壁细胞有显著直接作用,而是支持与组胺和胆碱能机制的增强相互作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验